Celiac disease: Quantity matters

Seminars in Immunopathology

Volumn 34, Issue 4, 2012, Pages 541-549

  Koning, Frits ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; GLIADIN; GLUTEN; GLUTENIN; HLA DQ ANTIGEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

AGE; AMINO ACID SEQUENCE; CD4+ T LYMPHOCYTE; CELIAC DISEASE; CELLULAR IMMUNITY; CROSS REACTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENOTYPE; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; IMMUNOSTIMULATION; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW; T LYMPHOCYTE ACTIVATION; WHEAT;

AGE FACTORS; CELIAC DISEASE; CROSS REACTIONS; GLUTENS; HLA-DQ ANTIGENS; HUMANS; MODELS, BIOLOGICAL; PEPTIDES; T-LYMPHOCYTES; TRITICUM;

EID: 84866139057     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-012-0321-0     Document Type: Review

References (45)

1. Koning F (2005) Celiac disease: Caught between a rock and a hard place. Gastroenterology 129:1294-1301
2. Abadie V, Sollid LM, Barreiro LB, Jabri B (2011) Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol 29:493-525
3. Trynka G, Wijmenga C, van Heel DA (2010) A genetic perspective on coeliac disease. Trends Mol Med 16:537-550
4. Shan L, Molberg Ø, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM, Khosla C (2002) Structural basis for gluten intolerance in celiac sprue. Science 297:2275-2279
5. van de Wal Y, Kooy Y, van Veelen P, Pena S, Mearin L, Molberg Ø, Lundin L, Mutis T, Benckhuijsen W, Drijfhout JW, Koning F (1998) Small intestinal cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci USA 95:10050-10054
6. Vader W, Kooy Y, van Veelen P, de Ru A, Harris D, Benckhuijsen W, Pena S, Mearin L, Drijfhout JW, Koning F (2002) The gluten response in children with recent onset celiac disease. A highly diverse response towards multiple gliadin and glutenin derived peptides. Gastroenterology 122:1729-1737
7. van de Wal Y, Kooy YMC, van Veelen P, August SA, Drijfhout JW, Koning F (2000) Glutenin is involved in the gluten-driven mucosal T cell response. Eur J Immunol 29:3133-3139
8. Molberg Ø, McAdam S, Körner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Norén O, Roepstorff P, Lundin KEA, Sjöström H, Sollid LM (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut derived T cells in celiac disease. Nat Med 4:713-717
9. van de Wal Y, Kooy YMC, van Veelen P, Peña AS, Mearin ML, Papadopoulos GK, Koning F (1998) Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 161:1585-1588
10. Sjostrom H, Lundin KEA, Molberg Ø, Korner R, McAdam S, Anthonsen D, Quarsten H, Noren O, Roepstorff P, Thorsby E, Sollid LM (1998) Identification of a gliadin T cell epitope in coeliac disease: General importance of gliadin deamidation for intestinal T cell recognition. Scand J Immunol 48:111-115
11. Arentz-Hansen H, Körner R, Molberg Ø, Quarsten H, Vader W, Kooy YMC, Lundin KEA, Koning F, Roepstorff P, Sollid LM, McAdam S (2000) The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 191:603-612
12. Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV (2000) In vivo antigen challenge in celiac disease identifies a single transglutaminase- modified peptide as the dominant A-gliadin Tcell epitope. Nat Med 6:337-342
13. Vader W, de Ru A, van der Wal Y, Kooy Y, Benckhuijsen W, Mearin L, Drijfhout JW, van Veelen P, Koning F (2002) Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med 195:643-649
14. Qiao SW, Ráki M, Gunnarsen KS, Løset GA, Lundin KE, Sandlie I, Sollid LM (2011) Posttranslational modification of gluten shapes TCR usage in celiac disease. J Immunol 187:3064-3071
15. Bodd M, Ráki M, Tollefsen S, Fallang LE, Bergseng E, Lundin KE, Sollid LM (2010) HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22. Mucosal Immunol 3:594-601
16. Hüe S, Mention J-J, Monteiro RC, Zhang SL, Cellier C, Schmitz J, Verkarre V, Fodil N, Bahram S, Cerf-Bensussan N, Caillat-Zucman S (2004) A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21:367-377
17. Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, Raulet DH, Lanier LL, Groh V, Spies T, Ebert EC, Green PH, Jabri B (2004) Coordinated induction by IL15 of a TCRindependent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21:357-366
18. Meresse B, Curran SA, Ciszewski C, Orbelyan G, Setty M, Bhagat G, Lee L, Tretiakova M, Semrad C, Kistner E, Winchester RJ, Braud V, Lanier LL, Geraghty DE, Green PH, Guandalini S, Jabri B (2006) Reprogramming of CTLs into natural killer-like cells in celiac disease. J Exp Med 203:1343-1355
19. Shewry PR (2009) Wheat. J Exp Bot 60:1537-1553
20. Tye-Din JA, Stewart JA, Dromey JA, Beissbarth T, van Heel DA, Tatham A, Henderson K, Mannering SI, Gianfrani C, Jewell DP, Hill AV, McCluskey J, Rossjohn J, Anderson RP (2010) Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease. Sci Transl Med 2(41):41-51
21. Vader W, Stepniak D, Kooy Y, Mearin ML, Thompson A, Spaenij L, Koning F (2003) The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of glutenspecific T-cell responses. Proc Natl Acad Sci USA 100:12390-12395
22. Stepniak D, Wiesner M, de Ru AH, Moustakas AL, Drijfhout JW, Papadopoulos GK, van Veelen PA, Koning F (2008) Large-scale characterization of natural ligands explains the unique glutenbinding properties of HLA-DQ2. J Immunol 180:3268-3278
23. Kooy-Winkelaar Y, van Lummel M, Moustakas AK, Schweizer J, Mearin ML, Mulder CJ, Roep BO, Drijfhout JW, Papadopoulos GK, van Bergen J, Koning F (2011) Gluten-specific T cells crossreact between HLA-DQ8 and the HLA-DQ2α/ DQ8β transdimer. J Immunol 187:5123-5129
24. Kim CY, Quarsten H, Bergseng E, Khosla C, Sollid LM (2004) Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci U S A 101:4175-4179
25. Henderson KN, Tye-Din JA, Reid HH, Chen Z, Borg NA, Beissbarth T, Tatham A, Mannering SI, Purcell AW, Dudek NL, van Heel DA, McCluskey J, Rossjohn J, Anderson RP (2007) A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease. Immunity 27:23-34
26. Molberg Ø, Solheim Flaete N, Jensen T, Lundin KE, Arentz-Hansen H, Anderson OD, Kjersti Uhlen A, Sollid LM (2003) Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease. Gastroenterology 125:337-344
27. Vader LW, Stepniak DT, Bunnik EM, Kooy YM, de Hann W, Drijfhout JW, van Veelen PA, Koning F (2003) Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology 125:1105-1113
28. Arentz-Hansen H, Fleckenstein B, Molberg Ø, Scott H, Koning F, Jung G, Roepstorff P, Lundin KE, Sollid LM (2004) The molecular basis for oat intolerance in patients with celiac disease. PLoS Med 1:e1, Epub 2004 Oct 19
29. Lundin KE, Nilsen EM, Scott HG, Løberg EM, Gjøen A, Bratlie J, Skar V, Mendez E, Løvik A, Kett K (2003) Oats induced villous atrophy in coeliac disease. Gut 52:1649-1652
30. Bodd M, Kim CY, Lundin KE, Sollid LM (2012) T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease. Gastroenterology 142:552-561
31. Spaenij-Dekking L, Kooy-Winkelaar Y, van Veelen P, Drijfhout JW, Jonker H, van Soest L, SmuldersMJM, Bosch D, Gilissen LJWJ, Koning F (2005) Natural variation in toxicity of wheat accessions for celiac disease patients. Potential for selection and breeding of nontoxic wheat varieties. Gastroenterology 129:797-806
32. Molberg O, Uhlen AK, Jensen T, Flaete NS, Fleckenstein B, Arentz-Hansen H, Raki M, Lundin KE, Sollid LM (2005) Mapping of gluten T-cell epitopes in the bread wheat ancestors: Implications for celiac disease. Gastroenterology 128:393-401
33. van Herpen TWJM, Goryunova SV, van der Schoot J, Mitreva M, Salentijn E, Vorst O, Schenk M, van Veelen PA, Koning F, van Soest L, Vosman B, Bosch D, Hamer RJ, Gilissen LJWJ, Smulders MJM (2006) Alpha-gliadin genes from the A, B, and D genomes are distinct in sequence conservation and celiac disease epitope content in diploid as well as hexaploid Triticum. Alpha-gliadin genes from the A, B, and D genomes of wheat contain different sets of celiac disease epitopes. BMC Genomics 7:1
34. Salentijn EM, Goryunova SV, Bas N, van der Meer IM, van den Broeck HC, Bastien T, Gilissen LJ, Smulders MJ (2009) Tetraploid and hexaploid wheat varieties reveal large differences in expression of alpha-gliadins from homoeologous Gli-2 loci. BMC Genomics 10:48
35. van den Broeck HC, de Jong HC, Salentijn EM, Dekking L, Bosch D, Hamer RJ, Gilissen LJ, van der Meer IM, Smulders MJ (2010) Presence of celiac disease epitopes in modern and old hexaploid wheat varieties: Wheat breeding may have contributed to increased prevalence of celiac disease. Theor Appl Genet 121:1527-1539
36. van den Broeck H, Hongbing C, Lacaze X, Dusautoir JC, Gilissen L, Smulders M, van der Meer I (2010) In search of tetraploid wheat accessions reduced in celiac disease-related gluten epitopes. Mol Biosyst 6:2206-2213
37. Gil-Humanes J, Pistón F, Tollefsen S, Sollid LM, Barro F (2010) Effective shutdown in the expression of celiac disease-related wheat gliadin T-cell epitopes by RNA interference. Proc Natl Acad Sci U S A 107:17023-17028
38. Mitea C, Salentijn EM, van Veelen P, Goryunova SV, van der Meer IM, van den Broeck HC, Mujico JR, Monserrat V, Gilissen LJ, Drijfhout JW, Dekking L, Koning F, Smulders MJ (2010) A universal approach to eliminate antigenic properties of alphagliadin peptides in celiac disease. PLoS One 5:e15637
39. Rizzello CG, De Angelis M, Di Cagno R, Camarca A, Silano M, Losito I, De Vincenzi M, De Bari MD, Palmisano F, Maurano F, Gianfrani C, Gobbetti M (2007) Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: New perspectives for celiac disease. Appl EnvironMicrobiol 73:4499-4507
40. Bethune MT, Strop P, Tang Y, Sollid LM, Khosla C (2006) Heterologous expression, purification, refolding, and structuralfunctional characterization of EP-B2, a self-activating barley cysteine endoprotease. Chem Biol 13:637-647
41. Ehren J, Govindarajan S, Morón B, Minshull J, Khosla C (2008) Protein engineering of improved prolyl endopeptidases for celiac sprue therapy. Protein Eng Des Sel 21:699-707
42. Stepniak D, Spaenij-Dekking L, Mitea C, Moester M, de Ru A, Baak-Pablo R, van Veelen P, Edens L, Koning F (2006) Highly efficient gluten degradation with a novel prolyl endoprotease from Aspergillus niger. Am J Physiol Gastrointest Liver Physiol 291: G621-G629
43. Mitea C, Havenaar R, Drijfhout JW, Edens L, Dekking L, Koning F (2008) Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: Implications for celiac disease. Gut 57:25-32
44. Gianfrani C, Siciliano RA, Facchiano AM, Camarca A, Mazzeo MF, Costantini S, Salvati VM, Maurano F, Mazzarella G, Iaquinto G, Bergamo P, Rossi M (2007) Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology 133:780-789
45. Sollid LM, Qiao SW, Anderson RP, Gianfrani C, Koning F (2012) Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenet 64 (6):455-460